Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Ceci

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 17, 2020
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics studyPierpaolo Alongi, Riccardo Laudicella, Alessandro Stefano, et al.
Frontiers in Surgery|July 29, 2021
Focal Therapy for Prostate Cancer: Complications and Their TreatmentArnas Rakauskas, Giancarlo Marra, Isabel Heidegger, et al.
Frontiers in Surgery|July 26, 2021
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?Fabio Zattoni, Isabel Heidegger, Veeru Kasivisvanathan, et al.
Clinical Nuclear Medicine|January 25, 2014
Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findingsEugenio Brunocilla, Francesco Ceci, Riccardo Schiavina, et al.
Endocrine|February 7, 2024
Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysisManila Rubino, Giuseppe Danilo Di Stasio, Lisa Bodei, et al.
Critical Reviews in Oncology/Hematology|September 8, 2023
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literatureGaia Piperno, Annamaria Ferrari, Stefania Volpe, et al.
Cancer Treatment Reviews|April 14, 2025
Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision OncologyFederica Giugliano, Elisa Giordano, Laura Gilardi, et al.
Clinical Genitourinary Cancer|June 4, 2018
Preoperative Staging With <sup>11</sup>C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate CancerRiccardo Schiavina, Lorenzo Bianchi, Federico Mineo Bianchi, et al.
European Urology Oncology|November 27, 2020
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?Isabel Heidegger, Andrea Necchi, Andreas Pircher, et al.
European Urology Oncology|December 22, 2021
Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer RecurrenceLorenzo Bianchi, Paolo Castellucci, Andrea Farolfi, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|June 17, 2020
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics studyPierpaolo Alongi, Riccardo Laudicella, Alessandro Stefano, et al.
Frontiers in Surgery|July 29, 2021
Focal Therapy for Prostate Cancer: Complications and Their TreatmentArnas Rakauskas, Giancarlo Marra, Isabel Heidegger, et al.
Frontiers in Surgery|July 26, 2021
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?Fabio Zattoni, Isabel Heidegger, Veeru Kasivisvanathan, et al.
Clinical Nuclear Medicine|January 25, 2014
Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findingsEugenio Brunocilla, Francesco Ceci, Riccardo Schiavina, et al.
Endocrine|February 7, 2024
Peptide receptor radionuclide therapy with 177Lu- or 90Y-SSTR peptides in malignant pheochromocytomas (PCCs) and paragangliomas (PGLs): results from a single institutional retrospective analysisManila Rubino, Giuseppe Danilo Di Stasio, Lisa Bodei, et al.
Critical Reviews in Oncology/Hematology|September 8, 2023
Hypofractionated proton therapy for benign tumors of the central nervous system: A systematic review of the literatureGaia Piperno, Annamaria Ferrari, Stefania Volpe, et al.
Cancer Treatment Reviews|April 14, 2025
Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision OncologyFederica Giugliano, Elisa Giordano, Laura Gilardi, et al.
Clinical Genitourinary Cancer|June 4, 2018
Preoperative Staging With <sup>11</sup>C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate CancerRiccardo Schiavina, Lorenzo Bianchi, Federico Mineo Bianchi, et al.
European Urology Oncology|November 27, 2020
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?Isabel Heidegger, Andrea Necchi, Andreas Pircher, et al.
European Urology Oncology|December 22, 2021
Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer RecurrenceLorenzo Bianchi, Paolo Castellucci, Andrea Farolfi, et al.
Pageof 15